Gilead Sciences Stock Hits a New All-Time High: Is it Still a Good Buy?
The healthcare stock has soared past the S&P 500 this year as its results have been strong in recent quarters.
Gilead Sciences (GILD) stock news
Every headline mentioning Gilead Sciences from Yahoo Finance, MarketWatch and Investing.com over the last 30 days, each scored for sentiment and importance. Updated automatically through the trading day.
Headlines1last 7 days · 6 in 30 days
Sentiment, 30 days
5 positive1 neutral0 negative
Latest headlineTue 10 Nov, 11:09 UTCHealthcare
Latest GILD headlines
Tuesday, 10 November 2026
Thursday, 5 November 2026
Gilead Sciences Has Raised Its Dividend for 11 Straight Years. Here's Why the Streak Looks Safe.
Gilead Sciences increased its quarterly dividend by 3.8% this year.
Friday, 30 October 2026
The big winners of the tech wreck are biopharma stocks
The shares of large drugmakers like Lilly, Gilead and J&J keep hitting record highs.
Thursday, 22 October 2026
Gilead to buy PepStar’s inflammation drug program in $1.28 billion deal
Gilead Sciences stock may move 4.6% on Oct. 29 earnings release
Thursday, 15 October 2026
Big pharma stocks close near all-time highs as tech selloff pushes investors toward safer bets
Shares of AbbVie, Eli Lilly and Gilead Sciences closed near record highs